Bio-Techne Releases Fourth Quarter Fiscal 2026 Results
Revenue$321.2 million+1% YoY
EPS$0.35
Company · TECH
Earnings coverage
Delayed up to 15 min · Source: Finnhub · Not investment advice
Widgets by TradingView. They load only when you click, so the page stays fast.
Forensic equity research on US stocks. No spam, unsubscribe anytime.